Original-clinicalReal-time three-dimensional echocardiography as a novel approach to assess left ventricular and left atrium reverse remodeling and to predict response to cardiac resynchronization therapy
Introduction
Cardiac resynchronization therapy (CRT) is considered an additional therapeutic option in heart failure patients who remain highly symptomatic despite optimized medical treatment.1 Large studies have shown a significant improvement in clinical and echocardiographic endpoints.2 However, up to 30% of the patients do not respond to CRT when selection is based on the traditional clinical and electrocardiographic criteria.3 In the search for better selection criteria for CRT, it has been shown that a direct echocardiographic assessment of left ventricular (LV) dyssynchrony is highly predictive for response to CRT.4 A novel echocardiographic technique has emerged for the assessment of LV dyssynchrony based on the analysis of regional volumetric changes: real-time 3-dimensional echocardiography (RT3DE). Promising results for the assessment of LV dyssynchrony have been shown when RT3DE was applied in patients with varying degrees of LV dysfunction and in normal subjects.5 Furthermore, we have recently shown the value of RT3DE to predict acute echocardiographic response to CRT.6 Clinically more important however, is the response at long-term follow-up. In the current study, the value of RT3DE both to assess LV reverse remodeling and to predict echocardiographic response to CRT was evaluated at 6-month follow-up.
In addition, it has been shown recently that RT3DE provides a highly accurate evaluation of left atrium (LA) size and function7, 8 that are established markers of adverse cardiovascular outcomes.9, 10, 11 Few data are available about the effect of CRT on LA remodeling and function.12 In the current study, it was hypothesized that a favorable response to CRT would also lead to an improvement in LA size and function.
Section snippets
Study population and protocol
The study population consisted of 57 consecutive patients with heart failure scheduled for CRT implantation. Traditional selection criteria for CRT were applied: New York Heart Association (NYHA) functional class III to IV, LV ejection fraction (EF) ≤35%, and QRS duration >120 ms. Patients with atrial fibrillation were excluded to allow a complete evaluation of LA function. Of note, acute results after CRT in 42 of these patients have been reported recently.6 Before CRT implantation and at
Pacemaker implantation
The LV pacing lead was inserted transvenously via the subclavian route and positioned as far as possible in a lateral or posterolateral vein. The right atrial and ventricular leads were positioned in the right atrial appendage (or on the right atrium lateral wall) and in the right ventricular apex, respectively. All patients received a combined device (CRT-D; Contak Renewal, Boston Scientific, St Paul, MN.; Insync III-CD or Insync Sentry, Medtronic Inc. Minneapolis, MN) without major
Statistical analysis
Continuous data are presented as mean ± standard deviation. Categorical data are presented as absolute numbers or percentages. The t test and chi-square test were used for appropriate comparisons. Changes in NYHA class, LV filling pattern, and mitral regurgitation before and after CRT have been evaluated with a Wilcoxon ranks test. To determine the relationship between baseline variables and echocardiographic response to CRT, logistic regression analysis was applied. First, univariate analysis
Study population
Six patients (10.5%) were excluded from further analysis because of suboptimal images; baseline characteristics of the remaining 51 patients are summarized in Table 1. RT3DE revealed severe LV dilatation (mean LV end-diastolic volume 200 ± 47 ml), with depressed LV function (mean LV EF 28% ± 6%). Furthermore, a moderate to severe LA dilatation (LAmax 40 ± 18 ml/m2) and dysfunction (LA EF 36% ± 14%) was observed.19, 20
Mean LV dyssynchrony (SDI) was 8.4% ± 3.9%, and the latest activated LV wall
Discussion
In the current study, RT3DE showed a significant improvement in LV remodeling and function at 6 months after CRT associated with a significant improvement in LA volumes and function. In addition, LV dyssynchrony (as measured with SDI) was the only predictor of echocardiographic response to CRT with high sensitivity and specificity.
Study limitations
The patient cohort was relatively small, and the predictive value of RT3DE needs to be assessed for clinical endpoints and confirmed in larger prospective studies. Data on scar tissue and the exact LV lead position were not systematically available, which have been shown to affect response to CRT.27, 28 Also, the contribution of reduction in mitral regurgitation on LA size and function after CRT should be explored in a larger group of patients.
Conclusion
RT3DE allows assessment of the effects of CRT on LV and LA volumes and function. Baseline LV dyssynchrony (as measured with SDI) is predictive for echocardiographic response to CRT.
References (28)
- et al.
Cardiac resynchronization therapy: caveat medicus!
J Am Coll Cardiol
(2004) - et al.
Cardiac resynchronization therapy: part 1—issues before device implantation
J Am Coll Cardiol
(2005) - et al.
Left atrial size: physiologic determinants and clinical applications
J Am Coll Cardiol
(2006) - et al.
Determinants and prognostic value of left atrial volume in patients with dilated cardiomyopathy
J Am Coll Cardiol
(2002) - et al.
Improvement of atrial function and atrial reverse remodeling after cardiac resynchronization therapy for heart failure
J Am Coll Cardiol
(2007) - et al.
Canadian consensus recommendations for the measurement and reporting of diastolic dysfunction by echocardiography: from the Investigators of Consensus on Diastolic Dysfunction by Echocardiography
J Am Soc Echocardiogr
(1996) - et al.
Left atrial volume as an index of left atrial size: a population-based study
J Am Coll Cardiol
(2003) - et al.
Normal left atrial function determined by 2-dimensional echocardiography
Am J Cardiol
(1983) - et al.
High-resolution transthoracic real-time three-dimensional echocardiography: quantitation of cardiac volumes and function using semi-automatic border detection and comparison with cardiac magnetic resonance imaging
J Am Coll Cardiol
(2004) - et al.
Structural and functional remodeling of the left atrium: clinical and therapeutic implications for atrial fibrillation
J Am Coll Cardiol
(2008)
Cardiac resynchronisation for patients with heart failure due to left ventricular systolic dysfunction—a systematic review and meta-analysis
Eur J Heart Fail
The effect of cardiac resynchronization on morbidity and mortality in heart failure
N Engl J Med
Real-time three-dimensional echocardiography: a novel technique to quantify global left ventricular mechanical dyssynchrony
Circulation
Real-time three-dimensional echocardiography permits quantification of left ventricular mechanical dyssynchrony and predicts acute response to cardiac resynchronization therapy
J Cardiovasc Electrophysiol
Cited by (68)
Left atrial strain provides incremental value for embolism risk stratification over CHA<inf>2</inf>DS<inf>2</inf>-VASc score and indicates prognostic impact in patients with atrial fibrillation
2014, Journal of the American Society of EchocardiographyAssociation between multilayer left ventricular rotational mechanics and the development of left ventricular remodeling after acute myocardial infarction
2014, Journal of the American Society of EchocardiographyUsefulness of overlapping of the e and A waves of the transmitral flow as a predictor of responders to cardiac resynchronization therapy
2013, American Journal of CardiologyCitation Excerpt :However, no single echocardiographic measurement of dyssynchrony appears to have had a clinically relevant impact in large clinical trials.2,3 Two-dimensional speckle-tracking imaging and real-time 3-dimensional echocardiography are promising methods to decrease nonresponse.12–17 However, the reproducibility of these echocardiographic parameters remains controversial.
Cardiac resynchronization considerations in left bundle branch block
2022, Frontiers in PhysiologyLeft atrial volume index predicts response to cardiac resynchronisation therapy: a systematic review and meta-analysis
2022, Archives of Medical ScienceImproved left atrial function in CRT responders: A systematic review and meta-analysis
2020, Journal of Clinical Medicine
Dr. Marsan is financially supported by the Research Fellowship of the European Society of Cardiology. Dr. Bax has received research grants from Medtronic, Boston Scientific, BMS medical imaging, St. Jude Medical, GE Healthcare. Dr. Schalij has received research grants from Biotronik, Medtronic, and Boston Scientific.